Primary central nervous system lymphoma (PCNSL) is a rare neoplasm, but it is occurring with increased frequency even among apparently immunocompetent patients. Although secondary malignancies frequently involve the lymphoreticular system, PCNSL has been reported as a second neoplasm only once previ
Quiescent nasal T/NK cell lymphoma manifested as primary central nervous system lymphoma
โ Scribed by Yeh, Kun-Huei; Lien, Huang-Chun; Hsu, Su-Ming; Cheng, Ann-Lii
- Publisher
- John Wiley and Sons
- Year
- 1999
- Tongue
- English
- Weight
- 64 KB
- Volume
- 60
- Category
- Article
- ISSN
- 0361-8609
No coin nor oath required. For personal study only.
โฆ Synopsis
A 57-year-old man was diagnosed as primary T/NK-cell central nervous system lymphoma (CNSL) with intraocular involvement. However, review of a surgical specimen taken three years before for chronic paranasal sinusitis revealed an overlooked nasal T/NK cell lymphoma (TNKL), which showed similar histomorphology and immunophenotype with the CNS disease. Another patient, a 43-year-old woman, was initially diagnosed as a rare primary leptomeningeal T-cell lymphoma with ocular manifestation. Three years later, an isolated nasal TNKL emerged. Immunohistochemical and cytogenetic studies confirmed the same nature of the CNSL and the nasal TNKL. The nasal TNKLs of both patients had a strong expression of CD3, CD56, and Epstein-Barr virus antigens, but features of angiodestruction and mucosal ulceration were absent. We propose that: 1. a locally silent ''quiescent'' form of nasal TNKL may exist; and 2. a thorough examination and even blind biopsy of the nasal cavity is indicated when primary T/NK-cell CNSL is diagnosed. Am.
๐ SIMILAR VOLUMES
## Abstract ## Objective: To evaluate YKLโ40 and MMPโ9 proteins as tumor biomarkers in serum samples from patients with primary central nervous system lymphoma (PCNSL). ## Methods: In this prospective longitudinal study, serum samples from consecutive patients with histologically confirmed PCNSL